Next to its immunomodulatory role via Tregs, TNFR2 promotes apoptosis of insulin-specific pathogenic autoreactive CD8+ T cells but not normal T cells isolated from diabetes type I patients (Ban et al., 2008). Here, TNFRSF1B is linked to type 1 diabetes mellitus.